[A case of interstitial pneumonia induced by gemcitabine hydrochloride for unresectable bile duct cancer]. 2009

Tomofumi Miura, and Nobuaki Suzuki, and Yutaka Ozeki, and Junichiro Nakamura, and Satoshi Yamada, and Tsutomu Miura, and Masahiko Yanagi, and Kazuhiro Sato, and Toru Takahashi
Division of Gastroenterology and Hepatology, Nagaoka Red Cross Hospital.

A 78-year-old man was admitted for obstructive jaundice and unresectable bile duct cancer on March 4, 2008. Since biliary drainage was extremely difficult, he began 2 treatment courses of gemcitabine hydrochloride (GEM 800 mg/m(2) on days 1, 8, 15 every 4 weeks). He suffered from dry cough and dyspnea on May 13, 2008. He was diagnosed as GEM-induced interstitial pneumonia with severe hypoxemia by CT scan and arterial blood gas examination. He recovered with two courses of steroid pulse therapy, diuretics and antibiotics. Alternatively, he was given oral S-1 ( 80 mg/m(2) 4 weeks on and 2 weeks off) from June 12, 2008. His QOL was well kept without jaundice for as long as a half year. This is the first report of GEM-induced interstitial pneumonia in bile duct cancer. In conclusion, interstitial pneumonia must be taken into consideration as a rare adverse reaction when GEM is used for biliary neoplasms.

UI MeSH Term Description Entries
D008297 Male Males
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000093542 Gemcitabine A deoxycytidine antimetabolite used as an antineoplastic agent. 2',2'-Difluoro-2'-Deoxycytidine,2',2'-Difluorodeoxycytidine,2'-Deoxy-2',2''-Difluorocytidine-5'-O-Monophosphate,2'-Deoxy-2'-Difluorocytidine,Gemcitabine Hydrochloride,Gemcitabine, (D-threo-pentafuranosyl)-Isomer,Gemcitabine, (alpha-D-threo-pentofuranosyl)-Isomer,Gemcitabine, (beta-D-threo-pentafuranosyl)-Isomer,Gemicitabine,2',2'-DFDC,Gemzar,LY 188011,LY-188011,dFdCyd,188011, LY,2' Deoxy 2' Difluorocytidine,2' Deoxy 2',2'' Difluorocytidine 5' O Monophosphate,Hydrochloride, Gemcitabine
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000964 Antimetabolites, Antineoplastic Antimetabolites that are useful in cancer chemotherapy. Antineoplastic Antimetabolites
D001650 Bile Duct Neoplasms Tumors or cancer of the BILE DUCTS. Bile Duct Cancer,Cancer of Bile Duct,Cancer of the Bile Duct,Neoplasms, Bile Duct,Bile Duct Cancers,Bile Duct Neoplasm,Cancer, Bile Duct,Cancers, Bile Duct,Neoplasm, Bile Duct
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin

Related Publications

Tomofumi Miura, and Nobuaki Suzuki, and Yutaka Ozeki, and Junichiro Nakamura, and Satoshi Yamada, and Tsutomu Miura, and Masahiko Yanagi, and Kazuhiro Sato, and Toru Takahashi
October 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Tomofumi Miura, and Nobuaki Suzuki, and Yutaka Ozeki, and Junichiro Nakamura, and Satoshi Yamada, and Tsutomu Miura, and Masahiko Yanagi, and Kazuhiro Sato, and Toru Takahashi
May 2010, Gan to kagaku ryoho. Cancer & chemotherapy,
Tomofumi Miura, and Nobuaki Suzuki, and Yutaka Ozeki, and Junichiro Nakamura, and Satoshi Yamada, and Tsutomu Miura, and Masahiko Yanagi, and Kazuhiro Sato, and Toru Takahashi
November 2015, Gan to kagaku ryoho. Cancer & chemotherapy,
Tomofumi Miura, and Nobuaki Suzuki, and Yutaka Ozeki, and Junichiro Nakamura, and Satoshi Yamada, and Tsutomu Miura, and Masahiko Yanagi, and Kazuhiro Sato, and Toru Takahashi
September 2003, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society,
Tomofumi Miura, and Nobuaki Suzuki, and Yutaka Ozeki, and Junichiro Nakamura, and Satoshi Yamada, and Tsutomu Miura, and Masahiko Yanagi, and Kazuhiro Sato, and Toru Takahashi
February 2005, Gan to kagaku ryoho. Cancer & chemotherapy,
Tomofumi Miura, and Nobuaki Suzuki, and Yutaka Ozeki, and Junichiro Nakamura, and Satoshi Yamada, and Tsutomu Miura, and Masahiko Yanagi, and Kazuhiro Sato, and Toru Takahashi
January 2024, International medical case reports journal,
Tomofumi Miura, and Nobuaki Suzuki, and Yutaka Ozeki, and Junichiro Nakamura, and Satoshi Yamada, and Tsutomu Miura, and Masahiko Yanagi, and Kazuhiro Sato, and Toru Takahashi
December 2021, Diagnostic and interventional imaging,
Tomofumi Miura, and Nobuaki Suzuki, and Yutaka Ozeki, and Junichiro Nakamura, and Satoshi Yamada, and Tsutomu Miura, and Masahiko Yanagi, and Kazuhiro Sato, and Toru Takahashi
January 1955, Cancer,
Tomofumi Miura, and Nobuaki Suzuki, and Yutaka Ozeki, and Junichiro Nakamura, and Satoshi Yamada, and Tsutomu Miura, and Masahiko Yanagi, and Kazuhiro Sato, and Toru Takahashi
February 2011, Hinyokika kiyo. Acta urologica Japonica,
Tomofumi Miura, and Nobuaki Suzuki, and Yutaka Ozeki, and Junichiro Nakamura, and Satoshi Yamada, and Tsutomu Miura, and Masahiko Yanagi, and Kazuhiro Sato, and Toru Takahashi
October 2016, BMC cancer,
Copied contents to your clipboard!